Bank of America’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.23M | Sell |
|
|||||
|
2025
Q2 | $7.05M | Sell |
|
|||||
|
2025
Q1 | $6.91M | Buy |
|
|||||
|
2024
Q4 | $3.73M | Sell |
|
|||||
|
2024
Q3 | $6.77M | Sell |
|
|||||
|
2024
Q2 | $7.09M | Buy |
|
|||||
|
2024
Q1 | $2.07M | Buy |
|
|||||
|
2023
Q4 | $388K | Buy |
|
|||||
|
2023
Q3 | $179K | Sell |
|
|||||
|
2023
Q2 | $491K | Buy |
|
|||||
|
2023
Q1 | $352K | Sell |
|
|||||
|
2022
Q4 | $275K | Buy |
|
|||||
|
2022
Q3 | $240K | Buy |
|
|||||
|
2022
Q2 | $158K | Sell |
|
|||||
|
2022
Q1 | $246K | Sell |
|
|||||
|
2021
Q4 | $579K | Buy |
|
|||||
|
2021
Q3 | $526K | Buy |
|
|||||
|
2021
Q2 | $511K | Sell |
|
|||||
|
2021
Q1 | $866K | Sell |
|
|||||
|
2020
Q4 | $1.23M | Sell |
|
|||||
|
2020
Q3 | $979K | Buy |
|
|||||
|
2020
Q2 | $712K | Buy |
|
|||||
|
2020
Q1 | $68K | Sell |
|
|||||
|
2019
Q4 | $72K | Buy |
|
|||||
|
2019
Q3 | $53K | Buy |
|
|||||
|
2019
Q2 | $51K | Buy |
|
|||||
|
2019
Q1 | $45K | Sell |
|
|||||
|
2018
Q4 | $105K | Buy |
|
|||||
|
2018
Q3 | $61K | Buy |
|
|||||
|
2018
Q2 | $42K | Buy |
|
|||||
|
2018
Q1 | $14K | Sell |
|
|||||
|
2017
Q4 | $12K | Buy |
|
|||||
|
2017
Q3 | $7K | Sell |
|
|||||
|
2017
Q2 | $51K | Sell |
|
|||||
|
2017
Q1 | $72K | Sell |
|
|||||
|
2016
Q4 | $67K | Buy |
|
|||||
|
2016
Q3 | $37K | Buy |
|
|||||
|
2016
Q2 | $20K | Buy |
|
|||||
|
2016
Q1 | $12K | Sell |
|
|||||
|
2015
Q4 | $41K | Buy |
|
|||||
|
2015
Q3 | $6K | Sell |
|
|||||
|
2015
Q2 | $35K | Buy |
|
|||||
|
2015
Q1 | $1K | Buy |
|